ESC 365 - Heart failure and comorbidities - what should we consider?

Open Access

Heart failure and comorbidities - what should we consider?

Session: Unleashing the potential benefits of guideline-directed heart failure treatments

Topic: Chronic Heart Failure

Speaker: Professor W. Mullens (Genk, BE)

Sponsored by Novartis Pharma AG

Event: Heart Failure 2022

Congress Presentation

About the speaker

Professor Wilfried Mullens

Hospital Oost-Limburg (ZOL), Genk (Belgium)

89 presentations

65 followers

7 more presentations in this session

Welcome and introduction.

Speaker: Doctor A. Bayes Genis (Badalona, ES)

Can we change the outlook for patients with HFrEF?

Speaker: Professor M. Petrie (Glasgow, GB)

Panel discussion.

Speaker: Doctor A. Bayes Genis (Badalona, ES) Professor M. Petrie (Glasgow, GB) Associate Professor M. Cikes (Zagreb, HR) Professor W. Mullens (Genk, BE)

Optimising treatment for hospitalised HF patients: what, when and how?

Speaker: Associate Professor M. Cikes (Zagreb, HR)

Panel discussion.

Speaker: Doctor A. Bayes Genis (Badalona, ES) Professor M. Petrie (Glasgow, GB) Associate Professor M. Cikes (Zagreb, HR) Professor W. Mullens (Genk, BE)

Access the full session

Unleashing the potential benefits of guideline-directed heart failure treatments

Speakers: Professor W. Mullens, Doctor A. Bayes Genis, Professor M. Petrie, Doctor A. Bayes Genis, Professor M. Petrie...

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by